Keystone Pharma Consulting Limited Filleted Accounts Cover
Keystone Pharma Consulting Limited
Company No. 09403717
Unaudited Accounts
31 March 2024
Keystone Pharma Consulting Limited Balance Sheet Registrar
at
31 March 2024
Company No.
09403717
2024
2023
£
£
Fixed assets
20,49632,493
Current assets
113,641105,223
Creditors: Amounts falling due within one year
(40,222)
(32,202)
Net current assets
73,41973,021
Total assets less current liabilities
93,915105,514
Accruals and deferred income
(1,388)
(764)
92,527104,750
Capital and reserves
92,527
104,750
NOTES TO THE ACCOUNTS
1
Basis of preparation
These accounts have been prepared in accordance with the micro-entity provisions of the small companies regime.
2
Employees
2024
2023
Number
Number
The average monthly number of employees (including directors) during the year was:
4
3
3
General information
Keystone Pharma Consulting Limited is a private company limited by shares and incorporated in England and Wales.
Its registered number is:
09403717
Its registered office is:
18 Yaverland Drive
Bagshot
Surrey
GU19 5DX
For the year ended 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.
The accounts were approved by the board of directors on 24 April 2024 and signed on its behalf by:
C.J. Morris - Director
Keystone Pharma Consulting Limited0940371731 March 202401 April 2023false24 April 2024BTCSoftware AP Solution 2024 11.1.0111.1.01The principal activity of the company during the year under review was the provision of consultancy services to the pharmaceutical sector. 094037172023-04-012024-03-31094037172024-03-31094037172023-03-3109403717core:WithinOneYear2024-03-3109403717core:WithinOneYear2023-03-31094037172022-04-012023-03-3109403717countries:UnitedKingdom2023-04-012024-03-3109403717bus:RegisteredOffice2023-04-012024-03-31094037172023-04-0109403717bus:Micro-entities2023-04-012024-03-3109403717bus:FullAccounts2023-04-012024-03-3109403717bus:AuditExempt-NoAccountantsReport2023-04-012024-03-3109403717bus:Director12023-04-012024-03-3109403717bus:PrivateLimitedCompanyLtd2023-04-012024-03-31iso4217:GBPxbrli:pure